Navigation Links
Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2008 Financial Results
Date:2/9/2009

the interest expense that the Company would likely incur on similar debt instruments without embedded conversion options. The additional interest expense recognized is based on the Company's estimate of the interest rates and terms of similar debt instruments without embedded conversion options. These estimates are subject to change as more information becomes available to the Company and the Company assumes no obligation to update these estimates after the date of this release.

Lincare, headquartered in Clearwater, Florida, is one of the nation's largest providers of oxygen and other respiratory therapy services to patients in the home. The Company provides services and equipment to approximately 700,000 customers in 48 states.

Statements in this release concerning future results, performance or expectations are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All forward-looking statements included in this document are based upon information available to Lincare as of the date hereof and Lincare assumes no obligation to update any such forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause Lincare's actual results, levels of activity, performance or achievements to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statements. In some cases, forward-looking statements that involve risks and uncertainties contain terminology such as "may," "will," "should," "could," "expects," "intends," "plans," "anticipates," "believes," "estimates," "predicts," "potential," or "continue" or variations of these terms or other comparable terminology.

Key factors that have an impact on Lincare's ability to attain any estimates contained in this release include potential reductions in reimburs
'/>"/>

SOURCE Lincare Holdings Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2007 Financial Results
2. Lincare Holdings Inc. Prices $500 Million Convertible Senior Debentures Offering
3. Lincare Holdings Inc. Reports Intention to File Shelf Registration Statement
4. Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results
5. Lincare Holdings Inc. Announces First Quarter 2008 Financial Results
6. Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2008 Financial Results
7. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
8. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
9. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
10. AHPC Holdings, Inc. Announces Intent to Deregister Common Stock With Securities and Exchange
11. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...v.25/PRNewswire-FirstCall/-- OnyxPharmaceuticals,...lhosttwoinvestoreventsinDecember: ,, ASHBrief...T ,, Principalinvestigatorswilldiscussdatapre...fractorymultiplemyeloma,asfeaturedatthe51stAmerica...ninNewOrleans,LA.Theteleconferencewillbeginat9:00a...
(Date:11/25/2009)....25/PRNewswire-USNewswire/--AnarticlebyJanetWoodco...ndResearch,titled"ADifficultBalance-PainManagement...eofTheNewEnglandJournalofMedicine. ,, (Logo: ht... ) ,, Inthearticle,WoodcockdiscussesFDAeffortst...sewhoneeditandmanagingtherisksposedbyvariousanalge...
(Date:11/25/2009)...ticular cancer who were treated with cisplatin-bas...uding neurological side effects and Raynaud-like p...therapy, according to a new study published online...r Institute . , Marianne Brydy, M.D., of the Dep..., in Bergen, Norway, and colleagues conducted a cr...
(Date:11/25/2009)...as too short to draw definite conclusions, experts... News) -- In diabetic patients with blocked corona...outcomes at one year whether patients undergo bypa...esearchers report. , Bypass surgery has been th...ronary artery disease. However, less invasive appr...
(Date:11/25/2009)...eurological symptoms, study finds , , W... side effects are among the potential problems fac... were treated with cisplatin-based chemotherapy, a...9 Norwegian men treated for unilateral testicular ...llow-up survey conducted from 1998 to 2002. , T...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3
... Ministers and NHS Staff use demeaning terms suc...ribe patients//, according to patients' tsar. T...Harry Cayton said such negative words shifted blam...ent flyers referring to patients who are in and ou...
... A doctor of Indian origin forged time sheets to c...ot do a day's work, the Newcastle Crown Court hear...ing hearings, the court was told that Dr Debasmita...ecause her work was not judged to be good enough. ...
... Following the recent scary outbreak of an epidemi...57:H7 which caused diarrhea// with bloody stools i...as been initiated to round up and annihilate the s... Samples of the suspected cattle dung are being te...
... This year, the Nobel prize for medicine has been ...IT and Craig C Mello of the Harvard University//, ...ytic process proposed to occur in plants, animals ... expression, controls the activity of ‘jumping gen...
... Leading doctors and scientists warned yesterday t...uses sucking their thumbs// and walking in the wom...nfluence on the public debate over abortion. ...ession that foetuses develop into viable and poten...
... President A.P.J. Abdul Kalam Tuesday urged medica...cus more on preventive care and report //negative ...to enable medical practitioners to take well infor... institutions should also spend significant amount...
Other Medicine News:Health News:NHS Reprimanded for Demeaning Words 2Health News:Indian Origin Doctor Faces Trial for Cheating 2Health News:Nobel Prize for Gene ‘Silencing 2Health News:New foetal scans are misleading 2
(Date:11/25/2009)...re-FirstCall/--Pharmasset,Inc.(Nasdaq: VRUS ),acli...ing,developingandcommercializingnoveldrugstotreatv...lyearendedSeptember30,2009.AtSeptember30,2009Pharm...tterminvestments. ,, PipelineUpdateand2009High..., InlateNovember2009,anindependentDataMonitoringCo...
(Date:11/25/2009)...wswire-FirstCall/--Formanyofthemillionsofhearingim...treated hearingloss ,theholidaysmaynotbeallthathap...rvicepresidentofHearUSA(Amex: EAR ),oneofAmerica,s...udieshavelinkedhearinglosstostress,frustration,and...daygatheringswithfamiliesandfriends,whenmanyofthos...
(Date:11/25/2009)...portlinker.comannouncesthatanewmarketresearchrepor...talDevicesMarketAnalysisandForecaststo2015 ,, ...s-Dental-Devices-Market-Analysis-and-Forecasts-to-...alysisandForecaststo2015 ,, Summary ,, Thi...ddatarelatingtotheUSdentaldevicesmarket.Italsooffe...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Partnership for Prescription Assistance Prepared to Help Wyoming Workers Hurt by Recession 48650 1Partnership for Prescription Assistance Prepared to Help Wyoming Workers Hurt by Recession 48650 2Partnership for Prescription Assistance Prepared to Help Wyoming Workers Hurt by Recession 48650 3Partnership for Prescription Assistance Prepared to Help Wyoming Workers Hurt by Recession 48650 4New American College of Surgeons risk calculator determines colorectal surgery risk 48647 1New American College of Surgeons risk calculator determines colorectal surgery risk 48647 2New American College of Surgeons risk calculator determines colorectal surgery risk 48647 3Brown 26 Toland Announces 2008 Financial Results 48645 1Brown 26 Toland Announces 2008 Financial Results 48645 2
...Multicenter Trial Will Test Ability of Adecatumuma...tients with Liver Metastases , , BETHESDA, Md., M...pharmaceutical company developing novel, proprieta...ation and autoimmune diseases, today announced the...trial of its human anti-EpCAM IgG1 antibody adecat...
...Innocoll, Inc., a privately-held biopharmaceutical... dosed in the second of two ongoing U.S. phase 3 c...diary, Innocoll Technologies Ltd, to investigate C...ention of surgical site infections. , , The trial...ites across the U.S. and has enrolled 600 patients...
Other Medicine Technology:Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 2Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 3Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 4Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 5Innocoll Announces Dosing of Last Patient in Second US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Colorectal Surgery Patients 2Innocoll Announces Dosing of Last Patient in Second US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Colorectal Surgery Patients 3
Graspers Atraumatic
Graspers Cupped
Scissors Punches
Rotary Scissors
Medicine Products: